NCT03576469: An overdue trial by IMMUNOe Research Centers
This trial is overdue. It was due to report 1 year, 1 month ago.
- We can only rely on the structured data that sponsors put into the registry: they may enter incorrect or incomplete data.
- Reporting in a journal is not enough. The FDAAA rules state that the trial must be reported on ClinicalTrials.gov.
- Terminated trials are required to report results. Only withdrawn trials (which never recruited a single patient) are not.
|Full entry on ClinicalTrials.gov||NCT03576469|
|Title||A Single-site, Open-Label, Pilot Study to Evaluate the Benefit of RUCONEST® in Subjects Who Experience ADRs Related to IVIG Infusions|
|ACT or pACT?||This is what FDAAA officially calls an "Applicable Clinical Trial"|
|Start date||June 13, 2018|
|Completion date||Dec. 1, 2019|
|Required reporting date||Nov. 30, 2020, midnight|
|Actual reporting date||None|
|Date last checked at ClinicalTrials.gov||Jan. 13, 2022|